ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
3 announcements with these filters
Hamps Bio Ltd announced the board meeting outcome, approving revised remuneration for its Chairman & Managing Director, Whole Time Director, CFO, and a Director.
Hamps Bio Ltd held its 19th Annual General Meeting on September 09, 2026, where shareholders transacted the businesses mentioned in the AGM notice.
Hamps Bio Ltd reported revenue from operations of ₹4.5 Cr (+45.2% YoY) and a net loss of ₹0.5 Cr for H2 FY26.